Cooperative Agreement W81XWH2120037
Award Date 9/15/21
Completion Date 9/14/23
Dollars Obligated $1.8M
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Stillwater, OK, USA
Similar Awards
- The Department of the Army Medical Command awarded a $600,000 cooperative agreement to Tufts University under the Military Medical Research and Development program (CFDA 12.420) for the period of September 1, 2022 through August 31, 2024. The purpose of this award is to develop a silk protein-based field-applicable spray for acute burn wound management. Through this funding, Tufts University will conduct research to investigate medical solutions for battlefield injuries, in line with the goals...
- The Department of the Army Medical Command awarded a $3,246,800 project grant to Duke University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop resorbable poly(ester urea) films for sustained delivery of meloxicam and bupivacaine to manage pain in critical combat casualty environments. Through basic, applied, and advanced biomedical research, the Military Medical Research and Development...
- The Department of the Army Medical Command awarded an $8.2 million cooperative agreement to the University of Utah from August 1, 2022 to July 31, 2026 under the Military Medical Research and Development program (CFDA 12.420). The award will support the prevention of lethal metastatic breast cancer by identifying and eradicating clinically relevant disseminated tumor cells. A $1.5 million subaward was provided to the University Health Network in Toronto, Canada to support related research...
- The Department of the Army Medical Command awarded a $1,419,356 project grant to Brigham & Women's Hospital Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to develop novel immunotherapy approaches to suppress cancer metastasis and recurrence in bone. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
- The Department of the Army Medical Command awarded $1.59 million to Children's Hospital Medical Center under the Military Medical Research and Development program (CFDA 12.420) for the period of June 15, 2022 to June 14, 2025. The project aims to investigate whether there is a point of convergence between congenital heart disease and autism by supporting basic, applied, and advanced biomedical research to transform military and public health care. The Military Medical Research and Development...
- The Department of the Army Medical Command awarded Ospedale San Raffaele S.R.L. a $650,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from September 30, 2022 to September 29, 2025 to engineer thymic selection to control the development of alloreactive T cells and promote vascularized composite allograft acceptance. The Military Medical Research and Development program aims to transform military and public health care...
- The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
- This Project Grant award of $2,234,452.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports research by the Henry M. Jackson Foundation for the Advancement of Military Medicine to develop a novel cryopreservation strategy for human red blood cells. The goal is to mitigate donor variability and oscillations in mosquito infectivity during controlled human malaria studies. The research project will be conducted from August 15, 2025...
- The Department of the Army Medical Command awarded The Methodist Hospital Research Institute $319,669 under the Military Medical Research and Development program (CFDA 12.420) for the period of June 1, 2021 through May 31, 2023. The project aims to investigate novel M2 lipogenic macrophages associated with fracture callus that are altered in type 2 diabetes. Baylor College of Medicine will serve as a sub-awardee to assist with the research. Through the support of basic, applied, and advanced...
- The Department of the Army Medical Command awarded a $695,089 Project Grant to the Dana-Farber Cancer Institute, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2022 to May 31, 2025 to develop noninvasive diagnosis of immune checkpoint inhibitor-associated myocarditis. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative...